Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$39K Hold
1,708
﹤0.01% 1728
2025
Q4
$46K Hold
1,708
﹤0.01% 1659
2025
Q3
$52K Hold
1,708
﹤0.01% 1636
2025
Q2
$54K Sell
1,708
-879
-34% -$29.1K ﹤0.01% 1572
2025
Q1
$99K Buy
2,587
+28
+1% +$1.19K ﹤0.01% 1484
2024
Q4
$112K Buy
2,559
+768
+43% +$33.7K ﹤0.01% 1476
2024
Q3
$77K Hold
1,791
﹤0.01% 1457
2024
Q2
$81K Buy
1,791
+635
+55% +$33K ﹤0.01% 1298
2024
Q1
$72K Buy
1,156
+474
+70% +$28.4K ﹤0.01% 1313
2023
Q4
$38K Hold
682
﹤0.01% 1687
2023
Q3
$36K Buy
+682
New +$39.7K ﹤0.01% 1683

Other funds holding ENOV

KBC Group's ENOV Position: Q1 2026 in Review

KBC Group held its Enovis (ENOV) position steady in Q1 2026 at 1,708 shares worth $39K. The position accounts for ﹤0.01% of the portfolio, ranked #1728.

KBC Group first reported a position in ENOV in Q3 2023 and has held it in 11 quarters since. The position peaked at $112K in Q4 2024. 254 funds tracked by Wall St. Rank hold ENOV as of Q1 2026.

  • KBC Group held 1,708 shares of Enovis worth $39K as of Q1 2026.
  • KBC Group left its Enovis share count unchanged in Q1 2026.
  • Enovis made up ﹤0.01% of KBC Group's portfolio in Q1 2026, its #1728 holding.
  • KBC Group first reported a position in Enovis in Q3 2023 and has held it in 11 quarters since.
  • KBC Group's Enovis position peaked at $112K in Q4 2024.
  • 254 funds tracked by Wall St. Rank held Enovis as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.